7.4. Exposure in equity investments and capital instruments

Print this page

The accompanying table shows the types, nature and amounts of the original exposures in equity investments listed or unlisted on a stock market, with an item differentiating sufficiently diversified portfolios and other unlisted instruments:

Table 43. Exposure in equity investments and capital instruments
2013

(Millions of euros)

	Type of exposure ⁽¹⁾
Item	Non-derivatives	Derivatives
Exchange-traded instruments	5,216	204
Non-exchange traded instruments	3,289	109
Included in sufficiently diversified portfolios	3,289	109
Other instruments	–	–
TOTAL	8,505	313

(1) Depending on their nature, equity instruments not included in Trading Book Activity will be separated into derivatives and non-derivatives. The amount shown refers to original exposure, i.e. gross exposure of value corrections through asset impairment and provisions, before applying risk mitigation techniques.

2012

(Millions of euros)

	Type of exposure ⁽¹⁾
Item	Non-derivatives	Non-derivatives
Exchange-traded instruments	3,547	94
Non-exchange traded instruments	2,608	–15
Included in sufficiently diversified portfolios	2,608	–15
Other instruments	–	–
TOTAL	6,155	79

As regards the amounts resulting from the sale or liquidation of capital instruments or equity investments, the bank registered losses of €2,366 million as of December 31, 2013 and profits of €49 million as of the close of 2012. This increase in losses is due mainly to the sale of China Citic, as mentioned in section 1.1.3.

In equity, the bank registered €94 million in profits as of December 2013 and losses of €125 million at the close of 2012.

The increase in exposure on the previous year is due to the aforementioned incorporation of the stake in China Citic Bank.

information of prudential relevance 2013

7.4. Exposure in equity investments and capital instruments